Avvisto Therapeutics LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersTiverton, RI
SAM.gov UEIDNF5RQ87RBC3
Avvisto Therapeutics manufactures Cycloset, an FDA-approved product described as a sympatholytic, dopamine agonist-insulin sensitizer for the treatment of Type 2 Diabetes. The company's product is supported by pre-clinical and clinical studies.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Avvisto Therapeutics LLC | Tiverton | RI | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.